Daraxonrasib, a new pancreatic cancer drug, cut the risk of death by 60% in a Phase 3 trial. A doctor explains how it works, ...

An investigational targeted therapy doubled survival compared with standard chemotherapy for pretreated individuals with ...

In a Phase III trial, Revolution Medicines' daraxonrasib almost doubled the survival length of people with advanced ...

As we age, our cells accumulate genetic changes—mutations—some of which open the door to cancer. Scientists call these ...

Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in ...

In today’s Health Alert, a potential breakthrough in one of the deadliest cancers. A new drug is showing remarkable results ...

Pancreatic cancer remains one of the deadliest diagnoses in oncology. Only about 13% of patients survive five years, and for ...

Pancreas divisum is the most common pancreatic disorder that develops before birth. This congenital condition affects less than 10% of people, but only about 5% experience symptoms. Usually, a case of ...

Stool changes with pancreatic cancer can include diarrhea, foul-smelling stool, constipation, and changes in stool color. The pancreas is an organ between the stomach and the spine that helps the body ...

Diabetes is a common condition, especially in older adults. It happens when the body cannot properly control blood sugar ...